Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
for Locally Advanced Pancreatic Adenocarcinoma
Drug: Peposertib
44 locations incl. Duarte
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT04172532·Phase 1, Phase 2·Recruiting